The new device uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The company now offers a full line of synthetic bone grafts and human tissue products for spine surgery.
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.